| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22,5 k € | — | — | — | — | 5,0 k € | -95.3% | 105,7 k € | ||||||
| Gross margin | 437,6 k € | +36.8% | 320,0 k € | +188.8% | -360,4 k € | -71.9% | -209,7 k € | +32.2% | -309,1 k € | -4934.6% | 6,4 k € | -93.0% | 91,3 k € | |
| EBITDA | -1,7 M € | -83.1% | -952,5 k € | +32.4% | -1,4 M € | -109.3% | -673,3 k € | -84.6% | -364,7 k € | -7041.8% | 5,3 k € | +503.9% | -1,3 k € | |
| Operating profit | -1,9 M € | -76.9% | -1,1 M € | +29.4% | -1,5 M € | -111.1% | -719,6 k € | -97.3% | -364,7 k € | -7041.8% | 5,3 k € | +503.9% | -1,3 k € | |
| Profit/loss | -2,0 M € | -81.2% | -1,1 M € | +28.5% | -1,6 M € | -107.0% | -752,2 k € | -105.6% | -365,9 k € | -7337.7% | 5,1 k € | +433.5% | -1,5 k € | |
| Equity | 3,2 M € | +96.5% | 1,6 M € | +2.4% | 1,6 M € | +289.8% | -834,5 k € | -134.3% | -356,2 k € | -3756.8% | 9,7 k € | +107.9% | 4,7 k € | |
| Total assets | 12,6 M € | +62.5% | 7,8 M € | +42.1% | 5,5 M € | +102.5% | 2,7 M € | +173.0% | 990,3 k € | +8615.0% | 11,4 k € | -66.0% | 33,4 k € | |
| Cash | 597,2 k € | +146.0% | 242,7 k € | +95.0% | 124,5 k € | -7.5% | 134,6 k € | -85.5% | 931,6 k € | +18472.8% | 5,0 k € | +225.7% | 1,5 k € | |
| Debts | 9,5 M € | +53.5% | 6,2 M € | +58.3% | 3,9 M € | +15.6% | 3,4 M € | +149.9% | 1,3 M € | +82860.2% | 1,6 k € | -94.3% | 28,7 k € | |
| Staff | 16,1 | 12,1 | — | — | — | — | — | |||||||
Private limited company · Ottignies-Louvain-la-Neuve · incorporated on 27/03/2018 · 16,1 ETP
Private limited company loss-making in the latest fiscal year. Cash position rising (+146.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Inteliphage is a Private limited company incorporated in 2018. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Ottignies-Louvain-la-Neuve. It employs on average 16,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette